Next Article in Journal
Recombinant Production of Snakin-2 (an Antimicrobial Peptide from Tomato) in E. coli and Analysis of Its Bioactivity
Previous Article in Journal
Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Diterpenoids from Saliva plebeia R. Br. and Their Antioxidant and Anti-Inflammatory Activities

1
School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China
2
Nanjing Sanhome Pharmaceutical Co., Ltd., Nanjing 210018, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2015, 20(8), 14879-14888; https://doi.org/10.3390/molecules200814879
Submission received: 24 May 2015 / Revised: 13 July 2015 / Accepted: 22 July 2015 / Published: 14 August 2015
(This article belongs to the Section Natural Products Chemistry)

Abstract

:
A new skeleton of diterpenoid, 1,2,3,4,4α,9,10,10α-octahydro-(4α-hydroxyymethyl)-1,1-dimethyl-9-(1-methylethyl)-(2S,3S,4αR,9R,10αS)-2,3,5,7-phenanthrenetertrol, named plebeianiol A (1), along with four known diterpenoids (25), were isolated from Salvia plebeia R. Br. Their structures were determined on the basis of spectral analysis. In the bioactivity tests, compounds 1, 2 and 5 showed 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activities with IC50 values of 20.0–29.6 µM. In addition, these three compounds had significant inhibitory effects on reactive oxygen species (ROS) production in lipopolysaccharide (LPS)-induced macrophages. Compounds 13 inhibited nitric oxide (NO) production in LPS-induced macrophages with IC50 values of 18.0–23.6 µM. These results showed that compounds 1, 2 had significant antioxidant and anti-inflammatory activities and might provide basis for the treatment of diseases associated with oxidative lesions and inflammation.

Graphical Abstract

1. Introduction

Salvia plebeia R. Br. is one of the genera from the Salvia family. It is widely distributed in many provinces of China. As a traditional Chinese medicine (TCM), it has been used to treat various diseases, such as urinary tract infection and bronchitis [1]. Modern pharmacological studies have shown that it exhibits anti-inflammatory [2], antioxidant [3], antitumor [4], hepatoprotective [5] and antimicrobial [6] activities. Phytochemical studies of S. plebeia R. Br. revealed the presence of flavonoids [7], terpenoids [8] and lignans [9].
In the course of researching bioactive components from S. plebeia R. Br., we found that ethyl acetate (EtOAc) fraction of S. plebeia R. Br. showed significant inhibitory activity against the production of NO in LPS-induced RAW 264.7 macrophages. According to the guidance of bioactivity, a new skeleton of diterpenoid (1) and four known diterpenoids (25) were isolated from the bioactive fractions of EtOAc fraction of S. plebeia R. Br. In the present study, we reported the isolation, structure elucidation, as well as antioxidant and anti-inflammatory activities of the isolated compounds in vitro.

2. Results and Discussion

The 80% aqueous ethanol extract of the air-dried herb of S. plebeia R. Br. was successively partitioned with petroleum ether, EtOAc and N-butyl alcohol (n-BuOH), respectively. Then five diterpenoids (15) (Figure 1) were isolated by successive column of the EtOAc fraction on silica gel, MCI column chromatography and Sephadex LH-20.
Figure 1. Structures of compounds 15.
Figure 1. Structures of compounds 15.
Molecules 20 14879 g001
Compound 1 was obtained as a yellow crystal. The molecular formula C20H30O5 was determined by high-resolution electrospray ionization mass spectrometry (HR-ESI-MS) (m/z 351.2159, [M + H]+, calcd for 351.2166), indicating six degrees of unsaturation. The melting point (m.p.) was 232–233 °C. The UV spectrum (194 and 211 nm) showed the absorption of conjugated double bond. Its IR spectrum exhibited the presence of hydroxyl (3455 cm−1) and phenyl group (1641, 1423, 875 and 699 cm−1).
The 1H-NMR spectrum showed signals of two independent phenolic hydroxyl groups at δH 9.61 (1H, brs, OH-5) and δH 7.54 (1H, brs, OH-7), two independent aromatic protons at δH 6.53 (1H, brs, H-6) and δH 6.35 (1H, brs, H-8), two alcohol hydroxyl groups at δH 4.51 (1H, d, J = 3.78 Hz), δH 4.39 (1H, d, J = 4.05 Hz) The 13C-NMR spectrum contained six carbon signals on the benzene ring, including δC 130.2 (C-4β), δC 143.0 (C-5), δC 126.3 (C-6), δC 141.6 (C-7), δC 117.5 (C-8), δC 131.9 (C-8α), three carbon signals were correlated with the hydroxyl at δC 81.8 (C-2), δC 66.8 (C-3) and δC 65.3 (C-16) (Table 1).
Table 1. 1H- (300 MHz) and 13C- (75 MHz) NMR data of compound 1 in DMSO-d6 (TMS, δ ppm; J in Hz).
Table 1. 1H- (300 MHz) and 13C- (75 MHz) NMR data of compound 1 in DMSO-d6 (TMS, δ ppm; J in Hz).
PositionδCδHPositionδCδH
138.6 1018.1I 1.50 (1H, m); II 1.60 (1H, m)
281.82.84 (1H, dd, J = 3.42, 5.79 Hz)10α52.11.30 (1H, m)
366.83.57 (1H, m)1129.61.01 (3H, s)
438.0I 0.96 (1H, m); II 3.36 (1H, d, J = 3.39 Hz)1218.10.78 (3H, s)
43.8 1331.72.74 (1H, m)
130.2 1422.31.10 (3H, d, J = 2.40 Hz)
5143.0 1522.41.11 (3H, d, J = 2.49 Hz)
6126.36.53 (1H, brs)1665.3I 3.73 (1H, d, J = 9.42 Hz); II 4.12 (1H, d, J = 9.84 Hz)
7141.6 2-OH 4.51 (1H, d, J = 3.78 Hz)
117.56.35 (1H, brs)3-OH 4.39 (1H, d, J = 4.05 Hz)
8131.9 5-OH 9.61 (1H, brs)
926.43.10 (1H, m)7-OH 7.54 (1H, brs)
DMSO: Dimethyl Sulfoxide.
1H detected heteronuclear multiple bond correlation (HMBC) correlations from H-9 (3.10, 1H, m) to C-14 (22.3), H-13 (2.74, 1H, m) to C-10 (18.1) and C-8α (131.9), H-14 (1.10, 3H, d, J = 2.40 Hz) to C-9 (26.4) revealed that the isopropyl in C-9. Key HMBC correlations were given in Figure 2. According to these, the structure 1, similar to the structure of 2α,3β,11,12-tetrahydroxy-7β,20-epoxy-8,11, 13-abietatriene [10], was established basically. The difference between the two compounds is that the ether bond does not exist in compound 1, along with the different locations of isopropyl and phenolic hydroxyls. This was the first time to report the isopropyl on the location of C-9. Further correlations from δH 3.10 (1H, m, H-9) with δH 3.73 (1H, d, J = 9.42 Hz, H-16-I), along with δH 3.57 (1H, m, H-3) with 4.12 (1H, d, J = 9.84 Hz, H-16-II) in the rotating frame overhauser effect spectroscopy (ROESY) spectrum suggested that H-3, H-9, H-16 were alpha-oriented. The correlations from δH 2.84 (1H, dd, J = 3.42, 5.79 Hz, H-2) with δH 1.30 (1H, s, H-10α), and δH 2.74 (1H, m, H-13) with δH 1.30 (1H, s, H-10α) suggested that H-2, H-10α and H-13 were on the same side. C-13 (the carbon that H-13 directly connected) is on the location of C-9 and in the opposite direction of H-9. So the correlations suggested that H-2, H-10α and H-13 were beta-oriented. Key ROESY correlations were given in Figure 3. Based on the above evidences, the structure of compound 1 was established to be 1,2,3,4,4α,9,10,10α-octahydro-(4α-hydroxyymethyl)-1,1-dimethyl-9-(1-methylethyl)-(2S,3S,4αR,9R,10αS)-2,3,5,7-phenanthrenetertrol and named plebeianiol A.
Figure 2. Key HMBC correlations of compound 1 (arrows points from H to C).
Figure 2. Key HMBC correlations of compound 1 (arrows points from H to C).
Molecules 20 14879 g002
Figure 3. Key ROESY correlations of compound 1.
Figure 3. Key ROESY correlations of compound 1.
Molecules 20 14879 g003
In the biosynthetic pathway, monoterpene A (3,4,5,5-tetramethyl-3-cyclohexen-1-ol) and monoterpene derivative B (3′,5′-dimethoxyl-2-methylpropiophenone) may contribute to the formation of compound 1. The original structure of compound 1 was formed through the combination of F and G. In addition, wittig reaction, friedel-crafts reaction and addition reaction were helpful to the establishment of target compound. The detailed process was showed in Scheme 1.
Scheme 1. Hypothetical biosynthetic pathway of compound 1.
Scheme 1. Hypothetical biosynthetic pathway of compound 1.
Molecules 20 14879 g004
By comparing the spectral data (MS, 1H-NMR, 13C-NMR) with the reported values, four known diterpenoids were identified as carnosol (2) [11], isocarnosol (3) [12], saficinolide (4) [13] and 2,11,12-trihydroxy-7,20-epoxy-8,11,13-abietatriene (5) [10].
The antioxidant activity of compounds 15 was evaluated by DPPH radical scavenging activity. The results showed that compounds 1, 2 and 5 had significant effects with IC50 values of 29.6, 28.8 and 20.0 µM, respectively (Table 2). Compared with Vitmain C (Vit. C), these three compounds showed similar antioxidant effects. In order to further evaluate the antioxidant effects, the ability to scavenge ROS in LPS-induced RAW 264.7 macrophages was measured at various concentrations (10, 30 and 100 µM) (Table 3). The results showed that compounds 1, 2 and 5 had significant effects along with the inhibition rates of 64.8%, 80.3% and 91.3% at the concentration of 100 µM. The results of intracellular ROS assay were similar to DPPH radical scavenging assay. The anti-inflammatory activity tests showed that compounds 13 inhibited NO production in LPS-induced macrophages with IC50 values of 18.0, 21.5 and 23.6 µM, respectively. In addition, RAW 264.7 macrophages were cultured with the obtained compounds at the concentration of 100 µM for 24 h and cell viability was evaluated using MTT assay. The cell viability was in the range of 91.6%–110.5% of the control. These results demonstrated that all compounds did not exhibit substantial cytotoxicity on RAW 264.7 macrophages. The anti-inflammatory experimental data and cell viability are shown in Table 4.
Table 2. DPPH radical scavenging activity of isolated compounds.
Table 2. DPPH radical scavenging activity of isolated compounds.
Compound5 (µM)10 (µM)20 (µM)30 (µM)50 (µM)IC50(µM)
116.6 ± 3.321.0 ± 1.839.2 ± 4.153.4 ± 8.275.4 ± 6.829.6
25.9 ± 1.615.4 ± 2.629.5 ± 1.959.3 ± 4.286.1 ± 3.328.8
33.4 ± 2.311.5 ± 2.424.5 ± 1.242.6 ± 6.049.0 ± 1.1>50
414.5 ± 2.915.2 ± 6.015.5 ± 1.37.0 ± 4.713.2 ± 1.5>50
59.2 ± 5.823.8 ± 6.655.4 ± 2.772.6 ± 5.789.6 ± 1.320.0
Vit. C6.1 ± 4.421.6 ± 2.243.8 ± 2.657.6 ± 5.489.1 ± 2.226.5
Table 3. Effects of isolated compounds on the production of intracellular ROS in LPS-stimulated RAW 264.7 macrophages.
Table 3. Effects of isolated compounds on the production of intracellular ROS in LPS-stimulated RAW 264.7 macrophages.
CompoundInhibition Rate (%)
10 (µM)30 (µM)100 (µM)
124.6 ± 2.4 **56.1 ± 8.2 *64.8 ± 5.2 **
229.5 ± 3.1 **53.2 ± 2.0 **80.3 ± 1.3 **
313.5 ± 1.116.0 ± 1.922.0 ± 1.8 **
48.1 ± 3.216.6 ± 4.4 *47.1 ± 6.1 **
513.0 ± 3.351.8 ± 2.2 **91.3 ± 9.2 **
ApocyninNDND92.9 ± 2.6 **
The results were expressed as the mean ± SD. of three independent experiments. * p < 0.05, ** p < 0.01, vs. model group. ND: Not Determined.
Table 4. Effects of compounds on NO production in LPS-stimulated RAW264.7 macrophages and cell viability.
Table 4. Effects of compounds on NO production in LPS-stimulated RAW264.7 macrophages and cell viability.
CompoundNO Inhibition Rate (%)IC50Cell Viability (% vs. Control)
3 (µM )10 (µM )30 (µM)100 (µM)100(µM)
118.0 ± 3.2 **42.9 ± 2.5 **68.9 ± 5.2 **86.6 ± 4.9 **18.097.3 ± 4.2
220.5 ± 2.6 **32.0 ± 4.8 **63.3 ± 5.3 **103.4 ± 5.9 **21.5110.5 ± 0.9
318.8 ± 3.0 **29.9 ± 5.0 **59.4 ± 4.7 **98.1 ± 6.5 **23.6106.7 ± 1.5
46.3 ± 2.411.9 ± 5.815.8 ± 4.4 *28.7 ± 5.3 **>100101.3 ± 5.0
55.7 ± 3.84.9 ± 7.316.4 ± 5.4 *25.6 ± 4.0 **>10091.6 ± 2.3
ibuprofenNDND32.3 ± 4.2 **NDNDND
The results were expressed as the mean ± SD. of three independent experiments. * p < 0.05, ** p < 0.01, vs. model group. ND: Not Determined.

3. Experimental Section

3.1. General Information

IR spectra recorded on a Bruker tensor 27 spectrometer KBr-disks (Bruker, Karlsruhe, Germany). Mass spectra were obtained on a MS 1100 SERIES LC/MSD Trap mass spectrometer (ESI-MS) (Shanghai, China) and HR-ESI-MS were recorded with an Agilent 1260 UPLC DAD 6530 QTOF mass spectrometer (Shanghai, China). Optical rotations were measured with a JASCO P-1020 polarimeter NMR spectra were recorded on Burker ACF-300 NMR spectrometers with TMS as internal standard. Column chromatography was performed on Silica gel H (100–200 mesh, 200–300 mesh, Qingdao Marine Chemical Co., Ltd, Qingdao, China) and Sephadex LH-20 (40–75 µm, Shanghai, China). Thin-layer chromatography was performed on Silica gel GF254 (Qingdao Marine Chemical Co., Ltd, Qingdao, China). The absorption was measured using Thermo Scientific Varioskan Flash (Thermo Fisher Scientific Co., Ltd, Shanghai, China). LPS (from Escherichia coli) and trypsin were purchased from Sigma-Aldrich (St. Louis, MO, USA). Fetal bovine serum (FBS) was purchased from Hangzhou Sijiqing Biological Engineering Materials Co., Ltd, (Hangzhou, China). The other chemicals used were of analytical grade (Tianjin Chemical Co., Ltd, Tianjin, China).

3.2. Plant Material

The air-dried herbs of S. plebeia R. Br. were purchased from the Pharmacy of Yi-Feng (Nanjing, China) in July 2013. The herb were collected from Nanning, Guangxi province, China (Production license: 20100109), and identified by Min-Jian Qin, China Pharmaceutical University (Nanjing, China). A voucher specimen (No. 20130702) was deposited in Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing, China.

3.3. Extraction and Isolation

The air-dried herb of S. plebeia R. Br. (5.0 kg) was soaked in 80% EtOH (90.0 L) at room temperature for 12 h and extracted under refluxed four times (3 h each). The combined extracts were filtered and solvent was recycled under reduced pressure with a rotary evaporator at 65 °C to obtain a black crude extract (1000.0 g). The extract was suspended in water (3000 mL) and re-extracted by sequentially with petroleum ether (3 × 3000 mL), EtOAc (3 × 3000 mL) and n-BuOH (3 × 3000 mL), respectively. Each partitioned fraction was dried at 60 °C under reduced pressure with a rotary evaporator, and the results were 150.0 g (petroleum ether extract), 260.0 g (EtOAc extract) and 200.0 g (n-BuOH extract), in turn.
The EtOAc fraction was subjected on the silica gel and the eluent was a gradient system of CH2Cl2/MeOH (200:1–0:1, v/v) to give nine fractions (Fr. 1–Fr. 9). Fr. 4 (40.0 g) was rechromatograhed on a silica gel column eluted with CH2Cl2/MeOH (50:1–0:1, v/v) to give seven subfractions (Fr. 1a–Fr. 1g). The subfraction Fr. 1d was rechromatograped on MCI column chromatography to remove the chlorophyll and eluted with MeOH/H2O (70:30, v/v). A yellow-brown solution was obtained and stored under normal temperature. Finally, some yellow crystals were precipitated from the solution. The pure compound 1 (27 mg) was obtained by filtering. The remaining subfractions were rechromatographed on silica gel column eluted with CH2Cl2/EtOAc (30:1–1:1, v/v) and purified with Sephadex LH-20 column chromatography (MeOH) to obtain four diterpenoids 2 (200 mg), 3 (45 mg), 4 (13 mg) and 5 (19 mg).

3.4. Spectral Data

Compound 1: C20H30O5, yellow crystal (CHCl3-MeOH, 15:1); [ α ] D 27 +25.8 (c 0.1, MeOH); m.p. 232–233 °C; UV (MeOH) λmax (log ε): 211 (3.69) nm; IR (KBr) νmax: 3455, 2957, 1641, 1423, 875, 669 cm−1; HR-ESI-MS, m/z: 351.2195 [M + H]+; 1H-NMR (300 MHz, DMSO-d6) δ: 9.61 (1H, brs, OH-5), 7.54 (1H, brs, OH-7), 6.53 (1H, brs, H-6), 6.35 (1H, brs, H-8), 4.51 (1H, d, J = 3.78 Hz, OH-2), 4.39 (1H, d, J = 4.05 Hz, OH-3), 4.12 (1H, d, J = 9.84 Hz, H-16-II), 3.73 (1H, d, J = 9.42 Hz, H-16-I), 3.57 (1H, m, H-3), 3.36 (1H, d, J = 3.39 Hz, H-4-II), 3.10 (1H, m, H-9), 2.84 (1H, dd, J = 3.42, 5.79 Hz, H-2), 2.74 (1H, m, H-13), 1.60 (1H, m, H-10-II), 1.50 (1H, m, H-10-I), 1.30 (1H, s, C-10α), 1.11 (3H, d, J = 2.49 Hz, H-15), 1.10 (3H, d, J = 2.40 Hz, H-14), 1.01 (3H, s), 0.96 (1H, s, H-4-I), 0.78 (3H, s, H-12); 13C-NMR (75 MHz, DMSO-d6) δ: 143.0 (C-5), 141.6 (C-7), 131.9 (C-8α), 129.9 (C-4β), 126.3 (C-7), 117.5 (C-8), 81.9 (C-2), 66.8 (C-3), 65.3 (C-16), 52.1 (C-10α), 43.8 (C-4α), 38.6 (C-1), 38.0 (C-4), 31.7 (C-13), 29.6 (C-11), 26.4 (C-9), 22.4 (C-15), 22.3 (C-14), 18.1 (C-10, 12).

3.5. Antioxidant Assay

DPPH radical assay: DPPH radical scavenging assay was performed according to previous protocol with modifications [14]. DPPH was dissolved in ethanol at the concentration of 200 µM. One hundred microliters of compounds (5, 10, 20, 30, 50 µM) were added to the 96-well plates, and evaded the light preservation for 30 min after addition 100 µL DPPH. Then the absorbance was measured at 517 nm using Thermo Scientific Varioskan Flash. Vitamin C was used as the positive control. The inhibitory effect was expressed as scavenging rate of alleviation and was calculated as follows:
Scavenging rate (%) = [1 − (A1 − A2)/A0] × 100
A1 refers to the absorbance with various concentrations of test compounds and DPPH, A2 refers to the absorbance with various concentrations of test compounds and ethanol, A0 refers to the absorbance with distilled water and DPPH.
Intracellular ROS assay: Intracellular ROS assay was performed according to the method reported previously [15]. RAW 264.7, a murine macrophage cell line, was obtained from the Pharmacognosy Laboratory of Prof. Mian Zhang, China Pharmaceutical University. Cells were cultured in DMEM containing 10% fetal bovine serum, 100 U/mL penicillin and 100 U/mL streptomycin at 37 °C in a humidified atmosphere containing 5% CO2 and 95% air. The cells (1 × 105 cells/well) were pre-incubated in the 96-well plate for 12 h. Then, cells were cultured in normal medium as normal group, or 1 μg/mL LPS as control group, or 1 μg/mL LPS plus different concentration of compounds as test group. After the cells of each group were treated for 6 h, the medium was removed, and the cells were incubated with 50 μL 2,7-Dichlorofluorescein diacetate (DCFH-DA) (10 μM) for 20 min at 37 °C. After that, the cells were washed with PBS carefully three times to remove free DCFH-DA. The absorbance was determined at 525 nm using Thermo Scientific Varioskan Flash. Apocynin was used as the positive control. The inhibitory rate (%) was calculated according to the equation:
Inhibition rate (%) = [1 − (B1 − B0)/(B2 − B0)] × 100
B1 refers to the absorbance of control group and B2 refers to the absorbance of test group, B0 refers to the absorbance of normal group.

3.6. Anti-Inflammatory Assay

The production of inflammatory mediators-NO in LPS-stimulated RAW 264.7 macrophages were used to evaluate the anti-inflammatory activity of testing drugs. The nitrite concentration was an indicator of NO production, and measured according to the Griess reaction in the culture medium [16]. After the cells of each group were treated as described above for 24 h, 100 μL of supernatant were mixed with 100 μL of Griess reagents (Reagent A: including 100 µg sulfanilamide and 600 µL 85% H3PO4 in 10 mL double distilled water; Reagent B: including 10 µg naphthyl ethylenediamine hydrochloride and 10 mL double distilled water; mixed equal volumes of reagents A and B) and standing for 10 min. The absorbance at 540 nm was measured using Thermo Scientific Varioskan Flash. The NO concentrations were calculated by regression analysis of a standard curve with sodium nitrite as a standard. The ibuprofen as the positive medicine was measured at the concentration of 30 µM. Inhibitory rate (%) was calculated according to the formula:
Inhibition rate (%) = [1 − (C1 − C0)/(C2 − C0)] × 100
C1 refers to the absorbance of control group and C2 refers to the absorbance of test group, C0 refers to the absorbance of normal group.

3.7. Cell Viability Assay

The MTT assay was used to evaluate the cell viability, as previously reported [17]. RAW 264.7 macrophages were seeded at a density of 1 × 105 cells /mL in 96-well plates and cultured for 24 h with the test compound (100 µM) at 37 °C in a 5% CO2 incubator. Subsequently, 20 μL of MTT solution (5 mg/mL) was added to each well and incubated for 4 h at 37 °C and the resulted crystals were dissolved in DMSO. The optical density was measured at 490 nm using Thermo Scientific Varioskan Flash.

4. Conclusions

In conclusion, five diterpenoids, including a new skeleton plebeianiol A, carnosol, isocarnosol, saficinolide and 2,11,12-trihydroxy-7,20-epoxy-8,11,13-abietatriene were identified from the EtOAc extract of S. plebeia R. Br. Compounds 1, 2 and 5 showed significant antioxidant activities. In addition, compounds 13 showed significant anti-inflammatory activities. These results showed that compounds 1, 2 had significant effects on antioxidant and anti-inflammatory activities.

Supplementary Materials

Supplementary materials can be accessed at: https://www.mdpi.com/1420-3049/20/08/14879/s1.

Acknowledgments

This project was supported by Natural Science Foundation of Jiangsu Province (No. BK 2012758), National New Drug Innovation Major Project of China (No. 2011ZX 09307-002-02), National College Students Innovation Project for the R & D of Novel Drugs (No. J1030830), Qing Lan Project of Jiangsu Province and the Priority Academic Program Development of Jiangsu Higher Education Institutions.

Author Contributions

Designed the experiments: Bao-Bao Zhang, Yan Liang and Fei-Hua Wu; performed the experiments: Bao-Bao Zhang, Bai-Qiu He, Biao Zeng, Xiao-Ji Shi, Yong Zhou, Ying Niu and Shi-Qi Nie; analyzed the results: Bao-Bao Zhang, Bai-Qiu He, Feng Feng and Jian-Bo Sun; and wrote the paper: Bao-Bao Zhang, Bai-Qiu He, Jian-Bo Sun and Fei-Hua Wu. All authors read and approved the final manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Peng, M.M.; Fang, Y.; Hu, W.; Huang, Q. The pharmaceutical activities of compound Salvia plebeia Granules on treating urinary tract infection. J. Ethnopharmacol. 2010, 129, 59–63. [Google Scholar] [CrossRef] [PubMed]
  2. Wu, F.H.; Wang, H.; Liang, J.Y.; Ma, S.P. Homoplantaginin modulates insulin sensitivity in endothelial cells by inhibiting inflammation. Biol. Pharm. Bull. 2012, 35, 1171–1177. [Google Scholar] [CrossRef] [PubMed]
  3. Gu, L.W.; Weng, X.C. Antioxidant activity and components of Salvia plebeia R. Br.—A Chinese herb. Food Chem. 2001, 73, 299–305. [Google Scholar] [CrossRef]
  4. Li, X.; Sui, X.Z. Clinical observation on treatment of lung cancer. China’s Naturopathy 2002, 10. [Google Scholar] [CrossRef]
  5. Jin, X.F.; Qian, J.; Lu, Y.H. The role of hepatoprotective effect of a flavonoid-rich extract of Salvia plebeia R. Br. on carbon tetrachloride-induced acute hepatic injury in mice. J. Med. Plants Res. 2011, 5, 1558–1563. [Google Scholar]
  6. Zhang, X.M.; Li, M.C.; Jiang, M.J.; Cheng, Y.Q. Antibacterial effect in vitro of extract from common sage herb by different polarity solvents. Pharm. Today 2014, 5, 328–330. [Google Scholar]
  7. Xiang, L.; Chen, H.N.; Xu, C.M.; Zhang, S.S.; Wang, H.Y. Study on flavonoids from Salvia plebeia. Pharm. J. Chin. 2008, 43, 813–815. [Google Scholar]
  8. Dai, Y.Q.; Liu, L.; Xie, G.Y.; Chen, Y.J.; Qin, X.Y.; Wang, Q.; Li, J.; Qin, M.J. Four new eudesmane-type sesquiterpenes from the basal leaves of Salvia plebeia R. Br. Fitoterapia 2014, 94, 142–147. [Google Scholar] [CrossRef] [PubMed]
  9. Ren, D.B.; Qin, Y.H.; Yun, Y.H.; Lu, H.M.; Chen, X.Q.; Liang, Y.Z. Separetion of nine compounds from Salvia plebeia R. Br. using two-step high-speed counter-current chromatography with different elution modes. J. Sep. Sci. 2014, 37, 2118–2125. [Google Scholar] [CrossRef] [PubMed]
  10. Xiong, Y.; Qu, W.; Sun, J.B.; Wang, M.H.; Liang, J.Y. Eudesmane sesquiterpenoid lactones and abietane diterpenoids from Ajuga forrestii Diels. Phytochem. Lett. 2013, 6, 457–460. [Google Scholar] [CrossRef]
  11. Rutherford, D.M.; Nielsen, M.P.C.; Hansen, S.K.; Witt, M.R.; Bergendorff, O.; Sterner, O. Isolation and identification from Salvia officinalis of two diterpenes which inhibit t-butylbicyclophosphoro [35S]thionate binding to chloride channel of rat cerebrocortical membranes in vitro. Neurosci. Lett. 1992, 135, 224–226. [Google Scholar] [CrossRef]
  12. Al-Hazimi, H.M.G.; Deep, M.S.; Miana, G.A. Isocarnosol, a new diterpene from Salvia lanigera. Phytochemistry 1984, 23, 919–921. [Google Scholar] [CrossRef]
  13. Tada, M.; Okuno, K.; Chiba, K.; Ohnishi, E.; Yoshii, T. Antiviral diterpenes from Salvia officinalis. Phytochemistry 1994, 35, 539–541. [Google Scholar] [CrossRef]
  14. Brand-Williams, W.; Cuverlier, M.E.; Berset, C. Use of a free radical method to evaluate antioxidant activity. Food Sci. Technol. 1995, 28, 25–30. [Google Scholar] [CrossRef]
  15. Liu, H.L.; Xu, R.; Feng, L.L.; Guo, W.J.; Cao, N.; Qian, C.; Teng, P.; Wang, L.; Wu, X.F.; Sun, Y.; et al. A novel chromone derivative with anti-inflammatory property via inhibition of ROS-dependent activation of TRAF6-ASK1-p38 pathway. PLoS ONE 2012, 7, e37168. [Google Scholar] [CrossRef] [PubMed]
  16. Green, L.C.; Wagner, D.A.; Glogowski, J.; Skipper, P.L.; Wishnok, J.S.; Tannenbaum, S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 1982, 126, 131–138. [Google Scholar] [CrossRef]
  17. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J. Immunol. Methods 1983, 65, 55–63. [Google Scholar] [CrossRef]
  • Sample Availability: Samples of the compounds 15 are available from the authors.

Share and Cite

MDPI and ACS Style

Zhang, B.-B.; He, B.-Q.; Sun, J.-B.; Zeng, B.; Shi, X.-J.; Zhou, Y.; Niu, Y.; Nie, S.-Q.; Feng, F.; Liang, Y.; et al. Diterpenoids from Saliva plebeia R. Br. and Their Antioxidant and Anti-Inflammatory Activities. Molecules 2015, 20, 14879-14888. https://doi.org/10.3390/molecules200814879

AMA Style

Zhang B-B, He B-Q, Sun J-B, Zeng B, Shi X-J, Zhou Y, Niu Y, Nie S-Q, Feng F, Liang Y, et al. Diterpenoids from Saliva plebeia R. Br. and Their Antioxidant and Anti-Inflammatory Activities. Molecules. 2015; 20(8):14879-14888. https://doi.org/10.3390/molecules200814879

Chicago/Turabian Style

Zhang, Bao-Bao, Bai-Qiu He, Jian-Bo Sun, Biao Zeng, Xiao-Ji Shi, Yong Zhou, Ying Niu, Shi-Qi Nie, Feng Feng, Yan Liang, and et al. 2015. "Diterpenoids from Saliva plebeia R. Br. and Their Antioxidant and Anti-Inflammatory Activities" Molecules 20, no. 8: 14879-14888. https://doi.org/10.3390/molecules200814879

Article Metrics

Back to TopTop